Farther Finance Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.88K | Sell |
135
-120
| -47% | -$3.45K | ﹤0.01% | 3447 |
|
|
2025
Q1 | $7.81K | Sell |
255
-306
| -55% | -$9.37K | ﹤0.01% | 2853 |
|
|
2024
Q4 | $28.7K | Buy |
561
+142
| +34% | +$7.26K | ﹤0.01% | 1921 |
|
|
2024
Q3 | $21.4K | Buy |
419
+412
| +5,886% | +$21K | ﹤0.01% | 2045 |
|
|
2024
Q2 | $322 | Hold |
7
| – | – | ﹤0.01% | 3378 |
|
|
2024
Q1 | $326 | Hold |
7
| – | – | ﹤0.01% | 3146 |
|
|
2023
Q4 | $249 | Buy |
+7
| New | +$249 | ﹤0.01% | 3176 |
|